Lower Costs, More Transparency Act of 2026
Current understanding
HR9393 (Lower Costs, More Transparency Act of 2026) is a House bill addressing healthcare cost reduction and price transparency, ordered to be reported in the nature of a substitute by a unanimous 45–0 committee vote. Substantive policy detail is not yet available at this procedural stage; the bill’s scope appears to span drug pricing and broader health cost/transparency topics.
Evidence log
- 2025-09-26 — Patients Deserve Price Tags Act: cross-connection with healthcare-price-transparency: Both measures pursue upfront price disclosure to patients, with the Patients Deserve Price Tags Act representing a narrower House bill in parallel to the broader Lower Costs, More Transparency Act. (novelty: 2)